In silico dissection of cell-type-associated patterns of gene expression in prostate cancer

被引:155
作者
Stuart, RO
Wachsman, W
Berry, CC
Wang-Rodriguez, J
Wasserman, L
Klacansky, I
Masys, D
Arden, K
Goodison, S
McClelland, M
Wang, YP
Sawyers, A
Kalcheva, I
Tarin, D
Mercola, D [1 ]
机构
[1] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA
[2] John & Rebecca Moores UCSD Canc Ctr, Dept Med, San Diego, CA USA
[3] John & Rebecca Moores UCSD Canc Ctr, Dept Family & Prevent Med, San Diego, CA USA
[4] John & Rebecca Moores UCSD Canc Ctr, Dept Family & Prevent Med, San Diego, CA USA
[5] John & Rebecca Moores UCSD Canc Ctr, Dept Pathol, San Diego, CA USA
[6] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA
[7] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA
关键词
microarray; expression profiles; linear regression; biomarkers; paracine;
D O I
10.1073/pnas.2536479100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prostate tumors are complex entities composed of malignant cells mixed and interacting with nonmalignant cells. However, molecular analyses by standard gene expression profiling are limited because spatial information and nontumor cell types are lost in sample preparation. We scored 88 prostate specimens for relative content of tumor, benign hyperplastic epithelium, stroma, and dilated cystic glands. The proportions of these cell types were then linked in silico to gene expression levels determined by microarray analysis, revealing unique cell-specific profiles. Gene expression differences for malignant and nonmalignant epithelial cells (tumor versus benign hyperplastic epithelium) could be identified without being confounded by contributions from stroma that dominate many samples or sacrificing possible paracrine influences. Cell-specific expression of selected genes was validated by immunohistochemistry and quantitative PCR. The results provide patterns of gene expression for these three lineages with relevance to pathogenetic, diagnostic, and therapeutic considerations.
引用
收藏
页码:615 / 620
页数:6
相关论文
共 22 条
[1]  
Blanchère M, 2001, PROSTATE, V46, P311, DOI 10.1002/1097-0045(20010301)46:4<311::AID-PROS1038>3.0.CO
[2]  
2-2
[3]  
Chiao JW, 1999, INT J ONCOL, V15, P1033
[4]  
DeVita VT, 2001, CANCER J, V7, P1
[5]   Delineation of prognostic biomarkers in prostate cancer [J].
Dhanasekaran, SM ;
Barrette, TR ;
Ghosh, D ;
Shah, R ;
Varambally, S ;
Kurachi, K ;
Pienta, KJ ;
Rubin, MA ;
Chinnaiyan, AM .
NATURE, 2001, 412 (6849) :822-826
[6]  
Di Como CJ, 2002, CLIN CANCER RES, V8, P494
[7]   Empirical Bayes analysis of a microarray experiment [J].
Efron, B ;
Tibshirani, R ;
Storey, JD ;
Tusher, V .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2001, 96 (456) :1151-1160
[8]   DNA microarrays in prostate cancer [J].
Ho S.-M. ;
Lau K.-M. .
Current Urology Reports, 2002, 3 (1) :53-60
[9]   Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends [J].
Howe, HL ;
Wingo, PA ;
Thun, MJ ;
Ries, LAG ;
Rosenberg, HM ;
Feigal, EG ;
Edwards, BK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (11) :824-842
[10]  
IHEKA R, 1996, J COMPUT GRAPH STAT, V5, P299